Metabolism of oxysterols derived from nonenzymatic oxidation of 7-dehydrocholesterol in cells

Libin Xu, Zeljka Korade, Dale A. Rosado, Karoly Mirnics, Ned A. Porter

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Recent studies suggest that 7-dehydrocholesterol (7-DHC)-derived oxysterols play important roles in the pathophysiology of Smith-Lemli-Opitz syndrome (SLOS), a metabolic disorder that is caused by defective 3 α -hydroxysterol- δ 7 -reductase (DHCR7). Although 14 oxysterols have been identified as the primary products of 7-DHC autoxidation in organic solution, the metabolic fate of these oxysterols in a biological environment has not yet been elucidated. Therefore, we incubated these primary 7-DHC oxysterols in control Neuro2a and control human fibroblast cells and identified metabolites of these oxysterols by HPLC-MS. We also incubated Dhcr7 -deficient Neuro2a cells and fibroblasts from SLOS patients with isotopically labeled 7-DHC ( d 7 -7- DHC). The observation of matching d 0 - and d 7 peaks in HPLC-MS confirmed the presence of true metabolites of 7-DHC after excluding the possibility of ex vivo oxidation. The metabolites of primary 7-DHC oxysterols were found to contribute to the majority of the metabolic profile of 7-DHC in cells. Furthermore, based on this new data, we identified three new 7-DHC-derived metabolites in the brain of Dhcr7 -KO mice. Our studies suggest that 7-DHC peroxidation is a major source of oxysterols observed in cells and in vivo and that the stable metabolites of primary 7-DHC oxysterols can be used as markers of 7-DHC peroxidation in these biological systems.

Original languageEnglish (US)
Pages (from-to)1135-1143
Number of pages9
JournalJournal of Lipid Research
Volume54
Issue number4
DOIs
StatePublished - Apr 1 2013

Fingerprint

Metabolism
Oxidation
Metabolites
Smith-Lemli-Opitz Syndrome
Fibroblasts
7-dehydrocholesterol
Oxysterols
High Pressure Liquid Chromatography
Metabolome
Biological systems
Brain
Oxidoreductases
Cells
Observation

Keywords

  • Fibroblast
  • Lipid peroxidation autoxidation
  • Mass spectrometry
  • Neuro2a
  • Smith -Lemli-Opitz syndrome

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Cell Biology

Cite this

Metabolism of oxysterols derived from nonenzymatic oxidation of 7-dehydrocholesterol in cells. / Xu, Libin; Korade, Zeljka; Rosado, Dale A.; Mirnics, Karoly; Porter, Ned A.

In: Journal of Lipid Research, Vol. 54, No. 4, 01.04.2013, p. 1135-1143.

Research output: Contribution to journalArticle

@article{352ce1c3c5cf4fe8a30823b78b88c284,
title = "Metabolism of oxysterols derived from nonenzymatic oxidation of 7-dehydrocholesterol in cells",
abstract = "Recent studies suggest that 7-dehydrocholesterol (7-DHC)-derived oxysterols play important roles in the pathophysiology of Smith-Lemli-Opitz syndrome (SLOS), a metabolic disorder that is caused by defective 3 α -hydroxysterol- δ 7 -reductase (DHCR7). Although 14 oxysterols have been identified as the primary products of 7-DHC autoxidation in organic solution, the metabolic fate of these oxysterols in a biological environment has not yet been elucidated. Therefore, we incubated these primary 7-DHC oxysterols in control Neuro2a and control human fibroblast cells and identified metabolites of these oxysterols by HPLC-MS. We also incubated Dhcr7 -deficient Neuro2a cells and fibroblasts from SLOS patients with isotopically labeled 7-DHC ( d 7 -7- DHC). The observation of matching d 0 - and d 7 peaks in HPLC-MS confirmed the presence of true metabolites of 7-DHC after excluding the possibility of ex vivo oxidation. The metabolites of primary 7-DHC oxysterols were found to contribute to the majority of the metabolic profile of 7-DHC in cells. Furthermore, based on this new data, we identified three new 7-DHC-derived metabolites in the brain of Dhcr7 -KO mice. Our studies suggest that 7-DHC peroxidation is a major source of oxysterols observed in cells and in vivo and that the stable metabolites of primary 7-DHC oxysterols can be used as markers of 7-DHC peroxidation in these biological systems.",
keywords = "Fibroblast, Lipid peroxidation autoxidation, Mass spectrometry, Neuro2a, Smith -Lemli-Opitz syndrome",
author = "Libin Xu and Zeljka Korade and Rosado, {Dale A.} and Karoly Mirnics and Porter, {Ned A.}",
year = "2013",
month = "4",
day = "1",
doi = "10.1194/jlr.M035733",
language = "English (US)",
volume = "54",
pages = "1135--1143",
journal = "Journal of Lipid Research",
issn = "0022-2275",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "4",

}

TY - JOUR

T1 - Metabolism of oxysterols derived from nonenzymatic oxidation of 7-dehydrocholesterol in cells

AU - Xu, Libin

AU - Korade, Zeljka

AU - Rosado, Dale A.

AU - Mirnics, Karoly

AU - Porter, Ned A.

PY - 2013/4/1

Y1 - 2013/4/1

N2 - Recent studies suggest that 7-dehydrocholesterol (7-DHC)-derived oxysterols play important roles in the pathophysiology of Smith-Lemli-Opitz syndrome (SLOS), a metabolic disorder that is caused by defective 3 α -hydroxysterol- δ 7 -reductase (DHCR7). Although 14 oxysterols have been identified as the primary products of 7-DHC autoxidation in organic solution, the metabolic fate of these oxysterols in a biological environment has not yet been elucidated. Therefore, we incubated these primary 7-DHC oxysterols in control Neuro2a and control human fibroblast cells and identified metabolites of these oxysterols by HPLC-MS. We also incubated Dhcr7 -deficient Neuro2a cells and fibroblasts from SLOS patients with isotopically labeled 7-DHC ( d 7 -7- DHC). The observation of matching d 0 - and d 7 peaks in HPLC-MS confirmed the presence of true metabolites of 7-DHC after excluding the possibility of ex vivo oxidation. The metabolites of primary 7-DHC oxysterols were found to contribute to the majority of the metabolic profile of 7-DHC in cells. Furthermore, based on this new data, we identified three new 7-DHC-derived metabolites in the brain of Dhcr7 -KO mice. Our studies suggest that 7-DHC peroxidation is a major source of oxysterols observed in cells and in vivo and that the stable metabolites of primary 7-DHC oxysterols can be used as markers of 7-DHC peroxidation in these biological systems.

AB - Recent studies suggest that 7-dehydrocholesterol (7-DHC)-derived oxysterols play important roles in the pathophysiology of Smith-Lemli-Opitz syndrome (SLOS), a metabolic disorder that is caused by defective 3 α -hydroxysterol- δ 7 -reductase (DHCR7). Although 14 oxysterols have been identified as the primary products of 7-DHC autoxidation in organic solution, the metabolic fate of these oxysterols in a biological environment has not yet been elucidated. Therefore, we incubated these primary 7-DHC oxysterols in control Neuro2a and control human fibroblast cells and identified metabolites of these oxysterols by HPLC-MS. We also incubated Dhcr7 -deficient Neuro2a cells and fibroblasts from SLOS patients with isotopically labeled 7-DHC ( d 7 -7- DHC). The observation of matching d 0 - and d 7 peaks in HPLC-MS confirmed the presence of true metabolites of 7-DHC after excluding the possibility of ex vivo oxidation. The metabolites of primary 7-DHC oxysterols were found to contribute to the majority of the metabolic profile of 7-DHC in cells. Furthermore, based on this new data, we identified three new 7-DHC-derived metabolites in the brain of Dhcr7 -KO mice. Our studies suggest that 7-DHC peroxidation is a major source of oxysterols observed in cells and in vivo and that the stable metabolites of primary 7-DHC oxysterols can be used as markers of 7-DHC peroxidation in these biological systems.

KW - Fibroblast

KW - Lipid peroxidation autoxidation

KW - Mass spectrometry

KW - Neuro2a

KW - Smith -Lemli-Opitz syndrome

UR - http://www.scopus.com/inward/record.url?scp=84875869346&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875869346&partnerID=8YFLogxK

U2 - 10.1194/jlr.M035733

DO - 10.1194/jlr.M035733

M3 - Article

C2 - 23381570

AN - SCOPUS:84875869346

VL - 54

SP - 1135

EP - 1143

JO - Journal of Lipid Research

JF - Journal of Lipid Research

SN - 0022-2275

IS - 4

ER -